10.6084/m9.figshare.c.3644222_D3.v1
Austin Nuschke
Austin
Nuschke
Melanie Rodrigues
Melanie
Rodrigues
Albin Wells
Albin
Wells
Kyle Sylakowski
Kyle
Sylakowski
Alan Wells
Alan
Wells
Additional file 3: Figure S3. of Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation
Springer Nature
2016
Multipotent stem cells
Mesenchymal stem cells
Glucose metabolism
Nutrient starvation
Stem cell survival
2016-12-01 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Figure_S3_of_Mesenchymal_stem_cells_multipotent_stromal_cells_MSCs_are_glycolytic_and_thus_glucose_is_a_limiting_factor_of_in_vitro_models_of_MSC_starvation/4468175
Theoretical interpretation of Seahorse metabolism output. Data on oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) adapted from the Seahorse Bio manual are plotted and outlined to highlight treatment rationale and subsequent interpretation. For OCR (left), basal mitochondrial respiration (A; blue) is disrupted with oligomycin treatment to inhibit ATP synthase and demonstrate ATP consumption (B; red), followed by FCCP treatment to uncouple the mitochondria and demonstrate maximal respiratory capacity (C; green). Rotenone treatment to completely inhibit complex I is then used to reduce OCR to non-mitochondrial respiration only (D; yellow). For ECAR (right), a preliminary dose of glucose is used to stimulate extracellular acidification through glycolysis (A; blue), followed by oligomycin treatment to again inhibit ATP synthase and yield maximal glycolytic capacity (B; green). 2-DG is finally used as a glucose analog to competitively inhibit glycolysis and return ECAR to non-glycolytic acidification levels (C; yellow). In our studies, both OCR and ECAR were assessed simultaneously through four treatment points using oligomycin, FCCP, 2-DG, and rotenone in sequence (see Fig. 2). Maximal respiratory and/or glycolytic capacities were assessed using the same rationale following FCCP or oligomycin treatment, respectively. (PDF 119 kb)